General Information of the Compound
| Compound ID |
CP0012881
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(2-phenylimidazo[1,2-a]pyridin-3-yl)benzamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
171628-57-2
AC1LF77Z
AKOS001415177
BDBM50187634
Benzamide, N-(2-phenylimidazo[1,2-a]pyridin-3-yl)-
CHEMBL379553
CTK0E4651
DTXSID60353680
HMS2842E11
MCULE-3771425109
MLS001162915
MolPort-002-132-975
N-(2-Phenylimidazo[1,2-a]pyridine-3-yl)benzamide
N-(2-phenylimidazo[1,2-a]pyridin-3-yl)benzamide
N-{2-phenylimidazo[1,2-a]pyridin-3-yl}benzamide
Oprea1_830806
SMR000495823
SR-01000196826
SR-01000196826-1
STK367224
ZINC193750
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H15N3O
|
||||||||||||||||||
| Molecular Weight |
313.36
|
||||||||||||||||||
| Canonical SMILES |
O=C(Nc1c(nc2ccccn12)-c1ccccc1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H15N3O/c24-20(16-11-5-2-6-12-16)22-19-18(15-9-3-1-4-10-15)21-17-13-7-8-14-23(17)19/h1-14H,(H,22,24)
Show/Hide
|
||||||||||||||||||
| InChIKey |
MFEAOWRPVOQOEV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound